Data on cases, clients, outside counsel and individual attorneys collected from active federal civil cases. Reflects only recently published court data; not intended to be exhaustive. Not responsible for errors in court dockets.
... Celgene Corp.'s blood cancer treatment drug Revlimid are at an increased risk of developing certain...
...Celgene Corp. has paid $350 million in cash to acquire Avila Therapeutics Inc., a biotechnology...
...The U.S. Food and Drug Administration chastised Celgene Corp. and Novartis AG in letters released...
830(Patent)
440(Civil Rights: Other)
Patent